DIADEMA PARTNERS LP

DIADEMA PARTNERS LP is an Investment Adviser institutional filer with the SEC under CIK 2026172, reporting 78 portfolio positions, with 13 historical 13F filings on file. Most recent reporting period: 2026-06-30.

A Form 13F reports a manager's US-listed stock and option positions only. It does not include real estate, private funds, bonds, cash or non-US holdings, so a 13F portfolio value is not the firm's total assets under management (AUM).

• State of incorporation: DE
• Filing type: 13F-HR
• Latest reporting period: 2026-06-30
• Last filed: 2026-08-14

Top 10 portfolio positions

The largest reported holdings in DIADEMA PARTNERS LP's most recent 13F filing, ranked by reported market value.

1. UNITED THERAPEUTICS CORP DEL (UTHR)
2. REVOLUTION MEDICINES INC (RVMD)
3. ABIVAX SA (ABVX)
4. COGENT BIOSCIENCES INC (COGT)
5. BRIDGEBIO PHARMA INC
6. BIOMARIN PHARMACEUTICAL INC (BMRN)
7. VIKING THERAPEUTICS INC (VKTX)
8. EDGEWISE THERAPEUTICS INC (EWTX)
9. KODIAK SCIENCES INC (KOD)
10. IMMUNOCORE HLDGS PLC (IMCR)